---
title: "Tofogliflozin - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: db11824-mesh-d003924-1.html
toc: false 
---


Path ID: `DB11824_MESH_D003924_1`
{% include image.html url="images/db11824-mesh-d003924-1.png" file="db11824-mesh-d003924-1.png" alt="db11824-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C575086 | Tofogliflozin | Drug |
| UniProt:P31639 | SGLT2 | Protein |
| GO:0035623 | Renal glucose absorption | BiologicalProcess |
| MESH:D001786 | Blood Glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tofogliflozin | DECREASES ACTIVITY OF | Sglt2 |
| Sglt2 | PREVENTS | Renal Glucose Absorption |
| Renal Glucose Absorption | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11824#mechanismofaction](https://go.drugbank.com/drugs/DB11824#mechanismofaction)
